GlassScriptPhysician profile
Cory A Messerschmidt
NPI 1609161728
$20,373.40
in general payments reported to CMS, 2019-2025
9 companies · $622 in 2025
The $622 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,411 · 2020: $464 · 2021: $5,963 · 2022: $3,155 · 2023: $5,719 · 2024: $39.47 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,488 · Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,488.44 |
| Food and Beverage | $891.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $12,105.98 | 2019-2023 | |
| Arthrex, INC. | $7,347.47 | 2019-2023 | |
| Stryker Corporation | $368.28 | 2025 | Mako |
| Zimmer Biomet Holdings, INC. | $257.92 | 2022-2025 | Avenir, Rosa |
| Bioventus LLC | $120.44 | 2021 | |
| Peerless Surgical INC. | $112.00 | 2025 | |
| Smith+Nephew, INC. | $24.51 | 2019 | |
| Ethicon US, LLC | $19.35 | 2025 | Megadyne |
| Boston Scientific Corporation | $17.45 | 2023 | Spaceoar Vue System - 10ml |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Messerschmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.